Search Results for agency_names:"Justice Department"

Medi-Physics Inc., doing business as GE Healthcare, has applied to register as an importer of certain controlled substances. They plan to use these substances for making a diagnostic product and reference standards but have not been authorized for other activities involving these substances. The public can submit comments or objections electronically by March 3, 2025, through the Federal eRulemaking Portal. Requests for a hearing on this application must also be submitted by the same date to the Drug Enforcement Administration.

Veranova, L.P. has applied to the Drug Enforcement Administration (DEA) to become an importer of specific controlled substances. These substances include Coca Leaves, raw Opium, Poppy Straw Concentrate, Thebaine, Noroxymorphone, and Fentanyl. The company intends to use these materials to manufacture active pharmaceutical ingredients and reference standards for testing purposes. The DEA invites public comments or objections by March 17, 2025, and requests for a hearing must be sent to the designated DEA addresses.

The Federal Bureau of Investigation (FBI), part of the Department of Justice, is planning to send a request to the Office of Management and Budget for approval to collect feedback through the Crime Data Explorer Feedback Survey. This survey aims to gather input from law enforcement, academia, and the general public to enhance the Crime Data Explorer's functionality. The FBI anticipates around 200 responses annually, with each response taking approximately two minutes. This is a continuation of a previously approved information collection, and public comments are invited until March 29, 2021.

The Department of Justice (DOJ), specifically the Bureau of Justice Statistics, is preparing to submit an information collection request to the Office of Management and Budget. This request relates to the renewal, with changes, of the Identity Theft Supplement, previously approved but now expired. This survey will be conducted as a part of the National Crime Victimization Survey to gather data on identity theft incidents among people over the age of 16 across the U.S. The survey aims to collect information about how identity theft occurs, its impact on victims, and how victims respond to incidents, with an estimated total public burden of 15,185 hours.

The U.S. Department of Justice and the Drug Enforcement Administration took action against Dr. David Bockoff, resulting in the revocation of his license to prescribe controlled substances. This decision came after a hearing revealed he had violated standards of care in prescribing powerful drugs without proper medical examinations or documentation. The government's investigation showed that between January 2020 and June 2022, he frequently prescribed these drugs in a manner inconsistent with both federal and California laws. Dr. Bockoff did not successfully challenge these findings or take responsibility, leading to the conclusion that his practices were dangerous to public health.

The Drug Enforcement Administration (DEA) has decided to revoke Dr. Yogesh Patel's DEA registration because he is not permitted to handle controlled substances as he lacks the authority to practice medicine in Colorado. The DEA's Order to Show Cause indicated that Dr. Patel's Colorado medical license is restricted, preventing him from practicing medicine, which is a critical requirement for maintaining his DEA registration. Dr. Patel did not request a hearing or dispute these allegations, leading to the revocation of his registration and denial of any pending applications. This decision was finalized by Acting Administrator Derek Maltz and will take effect on March 17, 2025.

The Open RF Association, Inc. has updated its membership by adding National Instruments from Austin, TX. This update was reported to the Attorney General and the Federal Trade Commission to ensure compliance with the National Cooperative Research and Production Act of 1993. The Act limits the financial recovery of antitrust plaintiffs to actual damages under certain conditions. The association plans to keep its membership open and will continue to report any further changes in its membership.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) is seeking public comments on a proposed extension, with changes, of an existing information collection. This involves the Report of Multiple Sale or Other Disposition of Certain Rifles—ATF Form 3310.12, which must be completed by firearms dealers in certain U.S. states for specific types of rifle sales. The proposed changes note a reduction in the number of respondents and associated public burden since the last review. Comments are open for 30 days, and the public is encouraged to give feedback on the necessity, accuracy, and utility of the information collected.

The Justice Department's Criminal Justice Information Services (CJIS) Division is seeking public comments on a proposed information collection activity. This involves the FBI Records Modification Form (FD-1115), which helps ensure criminal history information is accurately managed in compliance with privacy regulations. The form is necessary for state, local, Tribal, and Federal governments to edit their records accurately since manual updates may be required. Comments will be accepted until March 17, 2025, and focus on the necessity, accuracy, enhancement, and minimization of respondent burden related to the information collection.

Patheon API Manufacturing, Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances. The company intends to produce these substances as Active Pharmaceutical Ingredients (APIs) for its customers, specifically focusing on synthetic tetrahydrocannabinols. The public, including existing manufacturers and applicants, may submit comments or request a hearing on this application by April 20, 2021.